Loading data
IMDXNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 4.06 m USD | 1.88 m USD | 1.5 m USD | 958 k USD | 2.2 m USD |
| Cost of revenue | 1.75 m USD | 1.05 m USD | 1 m USD | 880 k USD | 697 k USD |
| Gross profit | 2.3 m USD | 740 k USD | 413 k USD | -18 k USD | 1.42 m USD |
| Research and development expense | 15.9 m USD | 9.84 m USD | 9.29 m USD | 7.3 m USD | 5.04 m USD |
| Operating profit | -51.12 m USD | -61.04 m USD | -25.14 m USD | -18 m USD | -53.73 m USD |
| Profit before tax | — | -60.66 m USD | -24.86 m USD | -18.61 m USD | -52.87 m USD |
| Income tax expense | 0 USD | 0 USD | — | — | -9.26 m USD |
| Net income (reported basis) | -50.22 k USD | -60.66 k USD | -27.78 k USD | -72.9 m USD | -64.1 m USD |
| Net income attributable to common shareholders | -50.22 m USD | -60.93 m USD | -28.72 m USD | -73.42 m USD | -64.1 m USD |
| Basic earnings per share | -1.65 USD/share | -4.66 USD/share | -3.75 USD/share | -13.25 USD/share | -0.72 USD/share |
| Diluted earnings per share | -1.65 USD/share | -4.66 USD/share | -3.75 USD/share | -13.25 USD/share | — |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.